To date, the identification of individuals at risk of suicide is based on subjective reports. Given that individuals at risk often do not disclose their suicidal thoughts, the introduction of objective measures - Such as biomarkers - of suicide risk might help in predicting which individuals will eventually die by suicide. Biomarkers have a potentially relevant role in the prediction of suicide, as an adjunct to, rather than a substitute for, current clinical practice. Within the context of the stress-diathesis model of suicidal behavior, the most relevant biomarkers for estimating suicide risk are non-suppression in the dexamethasone suppression test (DST) - a biomarker of stress - and reduced concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF), a biomarker of diathesis. Given the multi-determined nature of suicide, a combination of biological, clinical, neuropsychological, and neuroimaging factors might yield a better estimate of suicide risk than using biomarkers alone and help overcome current limitations in the prediction of suicide.
CITATION STYLE
Blasco-Fontecilla, H., & Oquendo, M. A. (2016). Biomarkers of suicide: Predicting the predictable? In Understanding Suicide: From Diagnosis to Personalized Treatment (pp. 77–83). Springer International Publishing. https://doi.org/10.1007/978-3-319-26282-6_7
Mendeley helps you to discover research relevant for your work.